.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Aiming for Precision Medicine in NSCLC

EP. 1: Promise of Immunotherapy in Lung Cancer

February 27th 2015

EP. 2: Intricacies of Checkpoint Inhibition in NSCLC

February 27th 2015

EP. 3: Immunotherapy in Non-Small Cell Lung Cancer

February 27th 2015

EP. 4: Clinical Utility of PD-L1 as a Biomarker in Lung Cancer

February 27th 2015

EP. 5: Personalized Medicine in NSCLC

February 27th 2015

EP. 6: Third-Generation EGFR Inhibitors in NSCLC

February 27th 2015

EP. 7: Development of Rociletinib and AZD9291 in NSCLC

February 27th 2015

EP. 8: Future Treatment Strategies for NSCLC

February 27th 2015